<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Care of patients with advanced dementia</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Care of patients with advanced dementia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Care of patients with advanced dementia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan L Mitchell, MD, MPH</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">R Sean Morrison, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Steven T DeKosky, MD, FAAN, FACP, FANA</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kenneth E Schmader, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Janet L Wilterdink, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jane Givens, MD, MSCE</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 05, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H423254512"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>As the population ages, the overall burden of advanced dementia is increasing worldwide. In the United States in 2022, an estimated 6.5 million individuals over 65 years of age had Alzheimer disease (AD), a number that is expected to reach 12.7 million by 2050 [<a href="#rid1">1,2</a>]. AD was the sixth leading cause of death among decedents &gt;65 years in 2017 [<a href="#rid3">3</a>]. Costs attributable to their care range between USD $157 and $215 billion and are expected to more than double by 2040 [<a href="#rid4">4</a>]. </p><p>Patients with advanced dementia and their caregivers are faced with a range of physical and psychosocial needs at the end of life. Palliative care is an interdisciplinary medical specialty that focuses on preventing and relieving suffering and on supporting the best possible quality of life for patients and their families facing serious illness. Effective palliative care of patients with advanced dementia can improve patients' symptoms, lessen caregiver burden, and help ensure that treatment decisions are well informed and weighed in the context of patient, family, and caregiver goals and needs.</p><p>Despite the evident magnitude of the problem, research to guide the management of advanced dementia has been somewhat limited, with few randomized clinical trials in the field [<a href="#rid5">5</a>].</p><p>This topic will review aspects of care that are specific to patients with advanced dementia. Other management issues in patients with dementia are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5082.html" rel="external">"Management of neuropsychiatric symptoms of dementia"</a> and  <a class="medical medical_review" href="/z/d/html/5080.html" rel="external">"Management of the patient with dementia"</a>.)</p><p class="headingAnchor" id="H2893225743"><span class="h1">PROGNOSIS AND CLINICAL DECISION-MAKING</span></p><p class="headingAnchor" id="H376278630"><span class="h2">Clinical course</span><span class="headingEndMark"> — </span>Advanced dementia typically refers to a state of profound physical and cognitive disability that is the result of a variety of neurodegenerative diseases, the most common of which is Alzheimer disease (AD). </p><p>The Global Deterioration Scale (GDS) describes the clinical progression of dementia [<a href="#rid6">6</a>]. Scores range from 1 to 7, with higher scores indicating greater dementia severity. The time course of progression through various stages is quite variable.</p><p>There is no single clinical definition of advanced dementia. Stage 7 of the GDS provides one useful description of advanced dementia: profound memory deficits (inability to recognize family members), speech limited to fewer than five words, total functional dependence, incontinence, and inability to ambulate [<a href="#rid7">7</a>]. Other studies use a score of 7 or higher on the Functional Assessment Staging (FAST) scale  (<a class="graphic graphic_table graphicRef89837" href="/z/d/graphic/89837.html" rel="external">table 1</a>) to identify patients with advanced dementia.</p><p>The last stage of life in advanced dementia is characterized by a prolonged trajectory of severe disability [<a href="#rid8">8</a>]. One cohort study followed 323 nursing home residents with advanced dementia [<a href="#rid9">9</a>]. Key findings included:</p><p class="bulletIndent1"><span class="glyph">●</span>Over the 18-month study period, 55 percent of the cohort had died, and the median survival was 1.3 years.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Infections and eating problems were common complications. Over the course of the study, 41 percent of the residents had pneumonia, 51 percent had a febrile episode, and 86 percent developed an eating problem. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Infections and eating problems were associated with high mortality. The adjusted six-month mortality rates after the development of pneumonia, a febrile episode, and eating problems were 47, 45, and 39 percent, respectively.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other major acute illnesses (eg, hip fracture, myocardial infarction) were rare in the last three months of life.</p><p></p><p>Other studies have also identified risk factors for early (six-month) mortality; these include infections (particularly pneumonia), pressure ulcers, immobility, malnutrition, indwelling urinary catheters, and comorbid systemic disease [<a href="#rid10">10-12</a>].</p><p class="headingAnchor" id="H423254526"><span class="h2">Predicted life expectancy</span><span class="headingEndMark"> — </span>Prognostication has important implications for clinical decision-making. One study found that patients with advanced dementia were less likely to have interventions such as feeding tubes, hospital transfers, bladder catheterizations, parenteral therapy, and venipunctures when their proxy's estimate of their life expectancy was shorter rather than greater than six months (4.4 versus 49.6 percent; adjusted odds ratio [OR] 0.46, 95% CI 0.34-0.62) [<a href="#rid13">13</a>]. </p><p>Life expectancy is also the basis to determine access to the United States Medicare hospice benefit, which requires an estimated survival of six months or less [<a href="#rid9">9,14</a>]. (See <a class="local">'Hospice eligibility'</a> below.)</p><p>However, mortality risk prediction models that accurately estimate survival in advanced dementia have proved elusive [<a href="#rid12">12,15-20</a>]. </p><p>In one rigorous effort, the Minimum Data Set [<a href="#rid21">21</a>] was used to create the Advanced Dementia Prognostic Tool (ADEPT), a 12-item additive score that includes patient age, sex, level of functional dependence, nutritional status, and presence or absence of various symptoms and medical conditions, such as congestive heart failure and shortness of breath [<a href="#rid22">22</a>]. In a prospective validation study of 606 nursing home residents with advanced dementia, ADEPT had a specificity of 89 percent and a sensitivity of 27 percent for predicting death within six months, which was only slightly better than current United States Medicare hospice eligibility guidelines, which had the same specificity but a lower sensitivity (20 percent) [<a href="#rid15">15</a>]. (See <a class="local">'Hospice eligibility'</a> below.)</p><p class="headingAnchor" id="H1180160338"><span class="h2">Framework for decision-making</span><span class="headingEndMark"> — </span>Medical decision-making in advanced dementia can be challenging. Decisions are made by surrogates if clear plans had not been made by the patient prior to cognitive decline. These decisions are often emotional and value laden, based on limited outcome data, and influenced by many external factors. Faced with these challenges, practitioners should be prepared to provide informative and compassionate decision support. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Health care proxies</strong> – Decision-making should follow an ethical framework reflecting a balance of benefits and burdens, and respect for autonomy [<a href="#rid23">23</a>]. Patients with advanced dementia have profound cognitive impairment, and decision-making therefore becomes the responsibility of their designated health care proxies. Proxies need to be advised that, when possible, their decisions should reflect their perceptions of the patient's wishes as guided by the steps for substitute decision-making [<a href="#rid24">24</a>]. (See  <a class="medical medical_review" href="/z/d/html/86248.html" rel="external">"Advance care planning and advance directives", section on 'Surrogate decision-makers'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Goals of care</strong> – Treatments received by patients with advanced dementia should align with their desired primary goals of care often as interpreted or perceived by the surrogate. The goal may reflect a wish to receive all available medical treatments, with the goal of living as long as possible. By contrast, the goal may reflect a wish to receive only treatments that relieve distressing symptoms, with the goal of maximizing comfort. Somewhere in between is the option of receiving potentially curative but conservative treatments (ie, oral antibiotics), with the goal of returning to the baseline status prior to the acute illness. In prospective studies of nursing home patients with advanced dementia, 62 to 90 percent of proxies stated a preference for comfort care over more aggressive options [<a href="#rid9">9,25</a>].</p><p></p><p class="bulletIndent1">These approaches are not necessarily mutually exclusive. Patients who wish to pursue potentially life-prolonging care can still receive treatments to reduce discomfort, and those opting for comfort-focused care for a particular problem may still receive potentially curative treatment for another. Within the context of these broad goals, treatment decisions must be tailored to each individual and clinical situation. (See  <a class="medical medical_review" href="/z/d/html/14240.html" rel="external">"Benefits, services, and models of subspecialty palliative care"</a> and  <a class="medical medical_review" href="/z/d/html/95552.html" rel="external">"Discussing goals of care"</a> and  <a class="medical medical_review" href="/z/d/html/86248.html" rel="external">"Advance care planning and advance directives"</a>.)</p><p></p><p class="headingAnchor" id="H1914808656"><span class="h2">Advance care planning</span><span class="headingEndMark"> — </span>Advance care planning is critical in the management of patients with advanced dementia, and it is the strongest and most consistent modifiable factor associated with avoiding unwanted or unnecessary treatments [<a href="#rid9">9,26-31</a>]. Primary care providers have an opportunity to prepare patients with early disease and their families about what to expect in the later stages of dementia [<a href="#rid9">9,32,33</a>]. </p><p>The standard components of advance care planning apply to advanced dementia and are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/86248.html" rel="external">"Advance care planning and advance directives"</a>.)</p><p>In patients with dementia, we emphasize the following points [<a href="#rid33">33,34</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Start early. Ideally, these discussions should occur before the patient loses decision-making capacity to allow the opportunity for individuals to participate and articulate their wishes. (See  <a class="medical medical_review" href="/z/d/html/98592.html" rel="external">"Assessment of decision-making capacity in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Discuss goals of care. These conversations should focus on the individual's values and preferences and provide a foundation for decision-making when future complications arise, both expected and unexpected. (See <a class="local">'Framework for decision-making'</a> above and  <a class="medical medical_review" href="/z/d/html/95552.html" rel="external">"Discussing goals of care"</a>.)</p><p></p><p class="bulletIndent1">Revisit this conversation, as the goals of care are likely to change along with the progression of the disease.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Establish directives in writing, including formal appointment of a health care proxy. (See  <a class="medical medical_review" href="/z/d/html/86248.html" rel="external">"Advance care planning and advance directives", section on 'Specific documents for health care decision-making'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Talk about what is to come. As dementia progresses, patients experience not only loss of cognition, but also the loss of basic bodily functions, particularly the ability to swallow correctly and fight infections. These complications are the most common proximate causes of death in advanced dementia. (See <a class="local">'Clinical course'</a> above.)</p><p></p><p class="bulletIndent1">In one study of over 300 nursing home residents with advanced dementia, residents whose proxies understood the clinical course and poor prognosis of the disease were less likely to receive aggressive interventions (hospital transfer, tube feeding, or intravenous [IV] therapy) in the last three months of life [<a href="#rid9">9</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Solicit specific treatment preferences (advance directives) before complications arise, if possible. Common issues that often arise in the management of advanced dementia include admission to a supervised health care setting (nursing home), placement of a feeding tube, and hospitalization.</p><p></p><p class="bulletIndent1">A lack of specific directives limiting aggressive care (eg, do not resuscitate, do not hospitalize) has been associated with greater use of feeding tubes [<a href="#rid35">35,36</a>], more terminal hospitalizations [<a href="#rid26">26,29,37,38</a>], more aggressive care for pneumonia [<a href="#rid39">39</a>], higher health care expenditures [<a href="#rid28">28,29</a>], worse family or caregiver satisfaction with end-of-life care [<a href="#rid40">40</a>], poorer family mental health outcomes [<a href="#rid41">41,42</a>], and lower use of hospice [<a href="#rid43">43</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Consider using a structured conversation guide and written materials tailored to patients and families with dementia [<a href="#rid32">32,44</a>]. Publicly available online resources include printable guides developed by The Conversation Project [<a href="#rid44">44</a>].</p><p></p><p class="bulletIndent1">Limited evidence suggests that structured interventions, such as palliative care consultation or decision aids, may be of benefit in patients with advanced dementia [<a href="#rid45">45,46</a>]. In one cluster randomized trial, use of a video decision aid and structured care plan meeting among families of patients with advanced dementia resulted in better communication about end-of-life care, increased use of medical orders defining scope of treatment, and fewer hospital transfers compared with an informational video and usual care plan meeting control [<a href="#rid46">46</a>]. Similarly, in another cluster randomized trial, an advance care planning video provided to 402 nursing home residents and their proxies was associated with increased proportion of those with directives for no tube feeding (70 versus 62 percent) [<a href="#rid25">25</a>]. While rates of advance directives for other interventions (eg, do not hospitalize) did not differ between study arms, a subgroup analysis found that for those who preferred comfort care, provision of the video was associated with higher rates of directives that aligned with that preference (72 versus 53 percent).</p><p></p><p class="headingAnchor" id="H3292078231"><span class="h2">Hospitalization</span><span class="headingEndMark"> — </span>Advance directives regarding hospitalization are an important example of advance care planning.</p><p>Hospitalization is common in patients with advanced dementia at the end of life and in many cases is avoidable. Approximately 16 percent of United States decedents dying from dementia die in hospitals [<a href="#rid47">47</a>], and nursing home residents with advanced dementia experience an average of 1.6 hospital transfers in the last 90 days of life [<a href="#rid48">48</a>]. It is estimated that 75 percent of hospitalizations among patients with advanced dementia are avoidable because hospital-level care is either unnecessary or inconsistent with preferences [<a href="#rid37">37</a>]. Data suggest that pneumonia, the most common reason precipitating hospitalization in these patients, can be treated with equal efficacy in the nursing home or community, with fewer burdens to the patient and less cost to the health care system [<a href="#rid39">39,49,50</a>].</p><p>Hospitalizations are traumatic and associated with worse end-of-life outcomes among patients with advanced dementia [<a href="#rid26">26,51</a>]. Hospitals are also a key site of treatment decisions, although decision-making is often suboptimal due to the discontinuity of care, unfamiliar providers, and pressures for timely discharge. For example, 68 percent of feeding tubes are placed in patients with advanced dementia during a hospital admission [<a href="#rid48">48</a>]. </p><p>For the majority of patients with advanced dementia for whom comfort is the priority, hospitalization is seldom consistent with this goal, with rare exceptions (eg, hip fracture) [<a href="#rid9">9,52</a>]. In most instances, the burdens of hospitalization outweigh the benefits and should be avoided. Providers should routinely counsel proxies and ascertain their preferences for hospitalizing their loved one with advanced dementia prior to the onset of an acute illness. The desire to avoid hospitalization should be formalized as a written advance directive or do-not-hospitalize order. </p><p class="headingAnchor" id="H4244271682"><span class="h1">HOSPICE AND PALLIATIVE CARE</span><span class="headingEndMark"> — </span>Hospice care provides medical care and support to a patient with a limited prognosis from a serious medical illness and their family/loved ones, with a focus on quality of life rather than life prolongation or cure. While hospice programs are beneficial, they are not a prerequisite for palliative care, which is appropriate in all patients with advanced dementia when consistent with the patient's goals of care. (See  <a class="medical medical_review" href="/z/d/html/2200.html" rel="external">"Hospice: Philosophy of care and appropriate utilization in the United States", section on 'Distinction between hospice and palliative care'</a>.)</p><p class="headingAnchor" id="H4059801461"><span class="h2">Benefits of hospice and palliative care approach</span><span class="headingEndMark"> — </span>Hospice referral or palliative care consultation should be included in the treatment options for patients with advanced dementia and their families. Although hospice has historically underserved patients dying with dementia, utilization in this population is increasing [<a href="#rid2">2,53</a>]. </p><p>Observational studies have found several benefits of hospice among patients with advanced dementia, including a lower probability of hospitalization during the last 30 days of life (19 versus 39 percent for hospice versus nonhospice patients) [<a href="#rid54">54</a>], a higher probability of regular treatment for daily pain (44 versus 27 percent) [<a href="#rid43">43,55</a>], and greater family and caregiver satisfaction with care [<a href="#rid43">43,56,57</a>].</p><p>Palliative care consultation to persons outside of hospice care also appears to have benefit. In one study of Medicare data from 21 nursing homes, nursing home residents with dementia who had palliative care consultations were somewhat less likely to be hospitalized or transferred to the emergency department in the 30 days before death [<a href="#rid58">58</a>]. In a randomized study of hospitalized patients with advanced dementia, families of patients who received a palliative care consult were more likely to opt for hospice care (25 versus 3 percent) and make decisions to avoid rehospitalization (13 versus 0 percent) [<a href="#rid59">59</a>].</p><p class="headingAnchor" id="H423254533"><span class="h2">Hospice eligibility</span><span class="headingEndMark"> — </span>In the United States, access to hospice is determined by <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cms.gov%2Fmedicare-coverage-database%2Fview%2Flcd.aspx%3Flcdid%3D33393%26ver%3D7%26NCAId%3D96%26NCDId%3D12%26ncdver%3D4%26SearchType%3DAdvanced%26CoverageSelection%3DBoth%26NCSelection%3DNCA%7CCAL%7CNCD%7CMEDCAC%7CTA%7CMCD%26ArticleType%3DEd%7CKey%7CSAD%7CFAQ%26PolicyType%3DFinal%26s%3D5%7C6%7C66%7C67%7C9%7C38%7C63%7C41%7C64%7C65%7C44%26KeyWord%3DHome%2BOxygen%26KeyWordLookUp%3DDoc%26KeyWordSearchType%3DAnd%26kq%3Dtrue%26bc%3DIAAAABgAAAAA%26%3D&amp;token=emJ%2B4O9hMBQJHKywcWldTb55vQgijqh9VcQ3aLhovxDYbQpfcochOJ1DRh7C7ed9tSa9pcWHrHZSchqv2vYGrFMbyieF1fYqzWu67KPS8wpPKPxZg%2FXrH3sQ8B16BJHiXOwpEKxlTAmhSIMwj8u9sAyWd9MIL8AnGPPQ%2FLp%2BLP8ih9Jc8lrHoJ%2FX0OqF3%2FfogmThgCQz9opxcHdQoqH1UTRuUGMG3eg0EDAF%2BAMAr6ILCzrqUAZaAu5bj1yAvvACD%2F9eoIEqZ2mPv6cdlbcxV5PMsGTZ%2BnjG%2B9yjKDorFIP0UhpJBU1gAMsA8Ru%2BbZ2g6dwDB%2FJgrEiUiQ3Egor8oKAtjMXnqRFnzq3IskNngxM%3D&amp;TOPIC_ID=86250" target="_blank">Medicare eligibility guidelines</a>, which are predicated on a predicted life expectancy of ≤6 months. The difficulty in estimating six-month survival in advanced dementia underscores the notion that access to palliative care for these patients should not be guided by estimates of life expectancy, but rather by patients' and families' preference to focus care on maximizing comfort and quality of life.</p><p>According to Medicare, patients with a primary diagnosis of dementia and related disorders must meet both of the following requirements to be eligible for hospice  (<a class="graphic graphic_table graphicRef89837" href="/z/d/graphic/89837.html" rel="external">table 1</a>): </p><p class="bulletIndent1"><span class="glyph">●</span>Stage 7 or beyond on the Functional Assessment Staging (FAST) scale [<a href="#rid60">60</a>]: unable to ambulate without assistance; unable to dress without assistance; unable to bathe without assistance; urinary and fecal incontinence, intermittent or constant; and no consistently meaningful verbal communication (stereotypical phrases only or the ability to speak is limited to six or fewer intelligible words)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The occurrence of at least one of six specified medical complications in the prior year:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Aspiration pneumonia</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pyelonephritis</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Septicemia</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Multiple decubitus ulcers stage ≥3 (see  <a class="medical medical_review" href="/z/d/html/2887.html" rel="external">"Clinical staging and general management of pressure-induced skin and soft tissue injury", section on 'Clinical evaluation'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Recurrent fever after antibiotics</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Inability to maintain sufficient fluid and calorie intake with 10 percent weight loss during the previous six months or serum albumin &lt;2.5 g/dL</p><p></p><p>Alternatively, patients are considered to have a life expectancy of ≤6 months by Medicare if they meet specific criteria for a decline in clinical status that is not considered to be reversible, independent of the underlying diagnosis  (<a class="graphic graphic_table graphicRef87321" href="/z/d/graphic/87321.html" rel="external">table 2</a>).</p><p class="headingAnchor" id="H423254575"><span class="h1">FEEDING AND NUTRITION</span><span class="headingEndMark"> — </span>The onset and progression of eating problems is a hallmark of advanced dementia, and nutritional support is one of the most common treatment decision faced by proxies of patients with advanced dementia [<a href="#rid61">61</a>]. </p><p class="headingAnchor" id="H180660748"><span class="h2">Causes and evaluation</span><span class="headingEndMark"> — </span>Eating problems in patients with advanced dementia are often multifactorial. Contributors include oral dysphagia (manifest by pocketing food in the cheeks or spitting food), pharyngeal dysphagia (which may result in delayed swallowing and aspiration, frequently leading to aspiration pneumonia), and an inability to perform the task of eating. Depression, while difficult to diagnose in advanced dementia, may also manifest as disinterest in food or refusal to eat. (See  <a class="medical medical_review" href="/z/d/html/2277.html" rel="external">"Oropharyngeal dysphagia: Etiology and pathogenesis", section on 'Etiology and pathogenesis'</a> and  <a class="medical medical_review" href="/z/d/html/1719.html" rel="external">"Diagnosis and management of late-life unipolar depression"</a>.) </p><p>At the onset of eating problems in a patient with advanced dementia, acute medical problems (eg, infection, stroke, medication side effects) need to be considered and excluded. Patients with new or worsened dysphagia caused by a stroke typically have acute neurologic signs and symptoms that extend beyond the dysphagia, such as dysarthria, asymmetric facial or limb weakness, or new aphasia. Easily reversible causes of eating problems should be addressed, such as constipation or dental problems.</p><p class="headingAnchor" id="H180660755"><span class="h2">Improving oral nutrition</span><span class="headingEndMark"> — </span>Various conservative measures to try to improve oral intake may be tried, including altering the texture of food; offering finger foods, smaller portions, or favorite foods; and using nutritional supplements [<a href="#rid62">62</a>].<sup> </sup>Many patients with dementia ultimately require assisted or hand feeding when they can no longer feed themselves. </p><p>Consultation by an occupational therapist, speech and language pathologist, or nutritionist is suggested in more functional patients to help assess and implement appropriate strategies. (See  <a class="medical medical_review" href="/z/d/html/95508.html" rel="external">"Swallowing disorders and aspiration in palliative care: Assessment and strategies for management", section on 'Facilitative swallowing strategies'</a>.)</p><p>A systemic review of oral feeding options for persons with various stages of dementia and eating problems concluded that there was moderate-quality evidence that high-calorie supplements promote weight gain, but low-quality evidence that appetite stimulants, assisted feeding, and modified foods (eg, lyophilized foods with modified texture) result in weight gain [<a href="#rid62">62</a>]. Sparse but consistent evidence showed that oral feeding options do not improve function, cognition, or mortality for people with moderate to severe dementia. </p><p class="headingAnchor" id="H180660962"><span class="h2">Oral versus tube feeding</span><span class="headingEndMark"> — </span>Despite conservative efforts to improve oral intake, most patients with advanced dementia will continue to have eating problems in the final stages of their illness. There are two main considerations in this situation: continued oral feeding by hand or placement of a long-term feeding tube (ie, percutaneous endoscopic gastrostomy [PEG] tube). </p><p>We suggest ongoing hand feeding rather than tube feeding as the preferred approach to nutritional support in patients with advanced dementia. This is the recommended approach of the American Geriatrics Society [<a href="#rid63">63</a>], the Canadian Geriatrics Society [<a href="#rid64">64</a>], and the American Board of Internal Medicine's Choosing Wisely Campaign [<a href="#rid65">65</a>]. The best available evidence fails to demonstrate any health benefits of tube feeding in advanced dementia, and there are risks associated with the intervention as discussed below [<a href="#rid23">23,66-68</a>]. </p><p>While oral feeding is increasingly preferred, decisions should be individualized. To facilitate decision-making, families and caregivers should be counseled that eating problems are expected in the final stage of dementia. With that understanding, providers should ascertain the main goal of care and present the treatment option that best aligns with that goal. Previously expressed wishes of an individual regarding tube feeding should be ascertained through review of advance directives and discussion with surrogate caregivers, and incorporated into the care plan [<a href="#rid63">63</a>]. Decision aids may assist in this process. As an example, in a cluster randomized trial in which 24 North Carolina nursing homes were randomly assigned to use of a decision aid for feeding options or standard care, surrogate decision makers in the intervention facilities had reduced decisional conflict, had increased knowledge, and were more likely to discuss eating problems with providers (46 versus 33 percent) [<a href="#rid69">69</a>]. The decision aid used in this study is available online through the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fdecisionaid.ohri.ca%2Fdocs%2Fdas%2Ffeeding_options.pdf&amp;token=k5P93xokiW7PNQLv0h7anFWF22iinxeot0MpFvi7Ul8hc8nI3JN5qfFtNdT4oezTFqWplxysvGPE2WimQ1K3zA%3D%3D&amp;TOPIC_ID=86250" target="_blank">Ottawa Hospital website</a>.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Oral feeding</strong> – Ongoing hand feeding rather than tube feeding is the preferred approach to nutritional support in patients with advanced dementia.</p><p></p><p class="bulletIndent1">The main goal of continued oral feeding is to provide food and drink to the extent that the patient enjoys it. This focus is on comfort rather than providing a prescribed daily caloric intake. Benefits of hand feeding include the continued pleasure of tasting food, insofar as it remains comfortable for the patient, and interaction with family members and caregivers during feeding times. However, conscientious hand feeding is labor intensive, requiring approximately 45 to 90 minutes per day [<a href="#rid70">70</a>]. Strategies that can improve the success of hand feeding include minimizing distractions, emphasizing sensory clues, providing assistive feeding utensils, optimizing patient positioning, and scheduling meals at times of greatest alertness and function. (See  <a class="medical medical_review" href="/z/d/html/95508.html" rel="external">"Swallowing disorders and aspiration in palliative care: Assessment and strategies for management", section on 'Additional suggestions'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tube feeding</strong> – The alternative approach, long-term tube feeding, is most often achieved by the placement of a PEG tube. Purported benefits for tube feeding in advanced dementia include prolonging life, preventing aspiration, improving malnutrition and its sequelae (ie, pressure sores), and alleviating symptoms of hunger or thirst [<a href="#rid71">71,72</a>].</p><p></p><p class="bulletIndent1">While there have been no randomized trials of tube feeding versus continued oral feeding in advanced dementia, the available evidence from observational studies does not suggest that enteral tube feeding achieves these outcomes. A 2021 systemic review (14 observational studies) found no evidence of benefit for survival, quality of life, pain, behavioral and psychological symptoms, nourishment, or improved family or carer outcomes such as depression, anxiety, carer burden, or satisfaction with care [<a href="#rid73">73</a>]. This review and other reviews also reported evidence suggesting that tube feeding may increase the risk of pressure ulcers and pneumonia [<a href="#rid68">68,74</a>].</p><p></p><p class="bulletIndent1">Families and caregivers should be apprised of the risks associated with PEG tube placement (see  <a class="medical medical_review" href="/z/d/html/2552.html" rel="external">"Gastrostomy tubes: Complications and their management"</a>). In addition, some studies have drawn attention to specific burdens of PEG tubes in patients with advanced dementia:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Tube dislodgment, blockage, or leakage was the most common reason for burdensome emergency department transfers in a large prospective study of nursing home patients with advanced dementia [<a href="#rid37">37</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Agitated patients may require physical or chemical restraints to prevent tube dislodgment, and tube feeding has been shown to be associated with greater use of restraints [<a href="#rid75">75</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a propensity-matched cohort study of 1124 hospitalized nursing home residents with advanced cognitive impairment and feeding problems, those who received a PEG tube during the hospitalization were 2.3 times <strong>more</strong> likely than those who did not receive a PEG tube to develop a new pressure ulcer over the next year, and were less likely to have an existing ulcer heal (adjusted odds ratio [OR] 0.70) [<a href="#rid76">76</a>]. </p><p></p><p class="headingAnchor" id="H423254582"><span class="h1">INFECTIONS AND FEVER</span><span class="headingEndMark"> — </span>Infections and fever are common in advanced dementia. They account for approximately one-quarter of all treatment decisions and are often terminal events. The respiratory and urinary tracts account for approximately one-half and one-third of all suspected infections, respectively [<a href="#rid77">77</a>]. The approach to treatment requires judicious consideration of the balance between the palliative care needs of the patient and standard infectious disease practice. </p><p class="headingAnchor" id="H1618720666"><span class="h2">Risks associated with antimicrobial misuse</span><span class="headingEndMark"> — </span>Antimicrobial use is extensive in advanced dementia, with up to 40 percent of patients receiving antimicrobials in the last few weeks of life [<a href="#rid77">77-79</a>]. Much of this use may be inappropriate, however, as antimicrobials are often started without adequate clinical evidence of an infection [<a href="#rid80">80-84</a>].</p><p>Antimicrobial misuse is a major concern not only from the perspective of individual patient burden, but also from a public health standpoint, due to the emergence of antimicrobial-resistant bacteria [<a href="#rid85">85</a>]. Antimicrobial exposure is the greatest risk factor for acquisition of resistance, and colonization rates with multidrug-resistant organisms are three times higher among nursing home residents with advanced dementia compared with other residents [<a href="#rid86">86</a>]. In a prospective cohort study, 67 percent of nursing home residents with advanced dementia were colonized with at least one multidrug-resistant organism during a 12-month follow-up period [<a href="#rid87">87</a>]. Residents had higher acquisition rates if they had received at least one day of exposure to quinolones (adjusted hazard ratio [aHR] 1.89, 95% CI 1.28-2.81) or third- or fourth-generation cephalosporins (aHR 1.57, 95% CI 1.04-2.40). (See  <a class="medical medical_review" href="/z/d/html/3807.html" rel="external">"Principles of infection control in long-term care facilities", section on 'Antimicrobial stewardship'</a>.)</p><p>Other risks of antimicrobial administration of particular concern in frail older adults include <em>Clostridioides difficile </em>infections [<a href="#rid88">88</a>], potential discomfort associated with parenteral administration [<a href="#rid51">51</a>], and drug interactions [<a href="#rid89">89</a>]. Detailed information on drug interactions can be found in the <a class="external" href="/drug-interactions">drug interaction program</a> within UpToDate.</p><p class="headingAnchor" id="H2552473"><span class="h2">Management of suspected pneumonia</span><span class="headingEndMark"> — </span>The evaluation and treatment of suspected infections in advanced dementia should be guided by the goals of care. One treatment decision is whether to administer potentially curative antimicrobials or to institute solely palliative measures (eg, oxygen, <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a>). Another management decision includes whether to refer the patient for hospitalization. (See <a class="local">'Hospitalization'</a> above.)</p><p>When antimicrobial use is consistent with the goals of care, a clinical assessment should ensure that antimicrobial therapy is indicated. The clinical assessment of suspected pneumonia is not straightforward in a patient with advanced dementia; the patient may not be able to provide a history or describe symptoms, and diagnostic tests are often less readily available. At the same time, empiric use of antimicrobials is discouraged as discussed above. The minimal clinical criteria to initiate antimicrobials in the nursing home population endorsed by the Society for Healthcare Epidemiology of America (SHEA) provide a useful guide that has been adapted for use in advanced dementia  (<a class="graphic graphic_table graphicRef89843" href="/z/d/graphic/89843.html" rel="external">table 3</a>) [<a href="#rid81">81</a>]. In one study, only 44 percent of suspected infectious episodes treated with antimicrobials in nursing home residents with advanced dementia met these criteria [<a href="#rid87">87</a>]. </p><p>Once the decision to initiate antimicrobials is made, the need for confirmatory tests (eg, chest radiograph, white cell count, urine specimen by catheterization) should be balanced by the potential burden of obtaining the investigations in these terminally ill patients.</p><p>In the absence of randomized trials, it remains unclear as to whether antimicrobial therapy for infections in advanced dementia improves survival or symptomatic relief beyond that which can be achieved by high-quality palliative care. As an example, in one observational study of 300 nursing home residents with advanced dementia, there were 225 pneumonia episodes treated with oral antimicrobials (55 percent), intramuscular (IM) antimicrobials (16 percent), intravenous (IV) antimicrobials or hospitalization (20 percent), or no antimicrobials (9 percent) [<a href="#rid39">39</a>]. Patients who received antimicrobials lived an average of 273 days longer than those who did not receive antimicrobials, but survival did not differ among the three antimicrobial routes. Residents receiving any form of antimicrobial treatment for pneumonia had worse comfort (lower scores on the Symptom Management at the End-of-Life in Dementia scale [<a href="#rid90">90</a>]) compared with untreated residents. These data, while limited, suggest that even when prolongation of life remains a goal, it may be possible to give antimicrobials orally, if appropriate, and avoid more aggressive parenteral treatment or hospitalization. </p><p>Specific recommendations for the management of pneumonia are provided separately. (See  <a class="medical medical_review" href="/z/d/html/117561.html" rel="external">"Overview of community-acquired pneumonia in adults", section on 'Treatment'</a> and  <a class="medical medical_review" href="/z/d/html/14606.html" rel="external">"Approach to infection in the older adult", section on 'Pneumonia'</a> and  <a class="medical medical_review" href="/z/d/html/7024.html" rel="external">"Aspiration pneumonia in adults"</a>.)</p><p class="headingAnchor" id="H2552467"><span class="h2">Management of suspected urinary tract infections</span><span class="headingEndMark"> — </span>Urinary tract infections (UTIs) are a common reason for antimicrobial misuse. In a prospective study of nursing home residents with advanced dementia, 80 percent of suspected UTIs treated with antimicrobials lacked minimal criteria to justify such treatment [<a href="#rid83">83</a>]. </p><p>The diagnosis of a UTI requires symptoms, together with positive findings on urinalysis and urine culture. In patients with advanced dementia, however, urine specimens are commonly positive in the absence of infection [<a href="#rid83">83</a>], and antimicrobial therapy is not warranted for asymptomatic bacteriuria [<a href="#rid81">81,91</a>]. The minimal clinical criteria to initiate antimicrobials in the nursing home population endorsed by SHEA provide a useful guide that has been adapted for use in advanced dementia  (<a class="graphic graphic_table graphicRef89843" href="/z/d/graphic/89843.html" rel="external">table 3</a>) [<a href="#rid81">81</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>Among patients without indwelling urinary catheters, who are at a much lower risk of having a UTI than catheterized patients, SHEA criteria  (<a class="graphic graphic_table graphicRef89843" href="/z/d/graphic/89843.html" rel="external">table 3</a>) require fever plus another symptom or sign as minimal clinical criteria to start antimicrobials [<a href="#rid81">81</a>]. In patients with advanced dementia, signs and symptoms of a UTI can be difficult to discern. Since patients are effectively mute, classic symptoms such as dysuria, urgency, costovertebral tenderness, and suprapubic pain are unreliable and rarely reported [<a href="#rid83">83</a>], and mental status change may be the only observable symptom. It is important to recognize, however, that mental status change alone is not a sensitive or specific symptom of UTI [<a href="#rid83">83</a>]. In most instances, therefore, both fever and mental status change should be present to justify antimicrobial initiation for a suspected UTI in a noncatheterized patient with advanced dementia  (<a class="graphic graphic_table graphicRef89843" href="/z/d/graphic/89843.html" rel="external">table 3</a>). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with an indwelling urinary catheter, fever alone may be adequate evidence for initiation when there are no additional symptoms (eg, new cough) to suggest an alternative source of infection  (<a class="graphic graphic_table graphicRef89843" href="/z/d/graphic/89843.html" rel="external">table 3</a>).</p><p></p><p>However, the benefit is uncertain, as antimicrobial treatment for suspected UTI may not impact overall survival [<a href="#rid92">92</a>]. Other issues specific to the evaluation and treatment of UTI in older adults are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/14606.html" rel="external">"Approach to infection in the older adult", section on 'Urinary tract infection'</a>.)</p><p>The specific antimicrobial management of UTI is discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/8063.html" rel="external">"Acute simple cystitis in adult and adolescent females"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/8059.html" rel="external">"Acute simple cystitis in adult and adolescent males"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/16109.html" rel="external">"Acute complicated urinary tract infection (including pyelonephritis) in adults and adolescents"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/8054.html" rel="external">"Catheter-associated urinary tract infection in adults"</a>.)</p><p></p><p>Antimicrobials should be discontinued as soon as the urinalysis and urine culture results are confirmed negative. If the tests results are positive, the provider must still apply clinical judgment to assess whether the combination of signs or symptoms and positive urine tests reflect a true UTI rather than another etiology.</p><p class="headingAnchor" id="H423254596"><span class="h1">OTHER MANAGEMENT ISSUES</span></p><p class="headingAnchor" id="H423254604"><span class="h2">Pain and symptom management</span><span class="headingEndMark"> — </span>Distressing symptoms in advanced dementia are common. In one study of over 300 nursing home patients with advanced dementia, nearly 25 percent of patients were reported to be in pain, 30 percent had dyspnea, and 30 percent had agitation in the last three months of life [<a href="#rid9">9</a>]. In a separate cohort evaluated for symptoms in the last week of life, the three most common symptoms were pain (52 percent), dyspnea (35 percent), and agitation (35 percent) [<a href="#rid93">93</a>].</p><p>Pain measurement is challenging in patients with profound cognitive impairment, and several disease-specific tools to assess pain and discomfort in advanced dementia have been developed [<a href="#rid90">90,94,95</a>]. Of these, we suggest using the Pain Assessment in Advanced Dementia (PAINAD) instrument, which is relatively easy to use and has proven reliability and validity  (<a class="graphic graphic_table graphicRef59509" href="/z/d/graphic/59509.html" rel="external">table 4</a>) [<a href="#rid94">94,96</a>]. PAINAD includes assessment of five different domains: breathing, negative vocalization, facial expressions, body language, and ability to be consoled. Scores range from 0 to 10, with higher scores indicating more severe pain. (See  <a class="medical medical_review" href="/z/d/html/2196.html" rel="external">"Approach to symptom assessment in palliative care", section on 'Pain'</a> and  <a class="medical medical_review" href="/z/d/html/83652.html" rel="external">"Palliative care: Nursing home", section on 'Assessing pain in patients with impaired cognitive function'</a>.) </p><p>Standard management approaches to alleviate physical discomfort (eg, dyspnea, pain) should be pursued in patients with advanced dementia and are discussed in detail separately. When possible, a specialized palliative care team or hospice referral should be sought to assist with symptom management. (See  <a class="medical medical_review" href="/z/d/html/14238.html" rel="external">"Assessment and management of dyspnea in palliative care"</a> and  <a class="medical medical_review" href="/z/d/html/2201.html" rel="external">"Ethical considerations in effective pain management at the end of life"</a> and  <a class="medical medical_review" href="/z/d/html/14241.html" rel="external">"Palliative care: The last hours and days of life", section on 'Pain'</a>.) </p><p>Nonpharmacologic and pharmacologic approaches to the management of agitation in patients with dementia are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5082.html" rel="external">"Management of neuropsychiatric symptoms of dementia"</a>.)</p><p class="headingAnchor" id="H1199892802"><span class="h2">Urinary incontinence</span><span class="headingEndMark"> — </span>When managing incontinence in adults with dementia, it should not be assumed that the cognitive impairment is the only cause of incontinence. Other factors (eg, functional impairment, comorbid conditions, and medications) should also be investigated and treated.</p><p>Goals of care and treatment preference discussions should include the needs and wishes of the caregivers who will oversee or implement treatment [<a href="#rid97">97</a>].</p><p>Nonpharmacologic approaches are preferred in persons with dementia. Pharmacotherapies, particularly anticholinergic medications, should be used with caution, as patients with dementia may experience more side effects [<a href="#rid98">98</a>]. (See  <a class="medical medical_review" href="/z/d/html/6881.html" rel="external">"Female urinary incontinence: Treatment", section on 'Cognitive impairment and functional incontinence'</a> and  <a class="medical medical_review" href="/z/d/html/14611.html" rel="external">"Urinary incontinence in men", section on 'Functional limitations'</a>.)</p><p>Strategies for managing urinary incontinence in the nursing home setting are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/3011.html" rel="external">"Medical care in skilled nursing facilities (SNFs) in the United States", section on 'Urinary incontinence'</a>.)</p><p class="headingAnchor" id="H423254619"><span class="h2">Discontinuing chronic medications</span><span class="headingEndMark"> — </span>The use of pharmaceutical agents in advanced dementia needs to be guided by the goals of care. Patients with advanced dementia often have swallowing problems, and discontinuing unnecessary medications can improve quality of life and reduce adverse effects. </p><p class="headingAnchor" id="H610168970"><span class="h3">Cholinesterase inhibitors and other antidementia drugs</span><span class="headingEndMark"> — </span>There is very limited evidence to support initiating dementia drugs, including cholinesterase inhibitors (ie, <a class="drug drug_general" data-topicid="9383" href="/z/d/drug information/9383.html" rel="external">donepezil</a>, <a class="drug drug_general" data-topicid="9529" href="/z/d/drug information/9529.html" rel="external">rivastigmine</a>, and <a class="drug drug_general" data-topicid="8739" href="/z/d/drug information/8739.html" rel="external">galantamine</a>) or <a class="drug drug_general" data-topicid="10131" href="/z/d/drug information/10131.html" rel="external">memantine</a> (an N-methyl-D-aspartate receptor antagonist), in patients with advanced dementia at a Global Deterioration Scale (GDS) stage of 7. The few clinical trials of these drugs that reported modest functional and cognitive improvements in "advanced" Alzheimer disease (AD) largely included subjects who had not yet reached GDS stage 7. Therapies targeting amyloid plaque that are approved for treatment in early AD are specifically contraindicated in advanced AD. All of these therapies are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5073.html" rel="external">"Treatment of Alzheimer disease", section on 'Cholinesterase inhibitors'</a> and  <a class="medical medical_review" href="/z/d/html/5073.html" rel="external">"Treatment of Alzheimer disease", section on 'Advanced disease'</a>.)</p><p>For patients with advanced dementia already on these drugs, it may be reasonable to discontinue them and only restart them in the event of patient decline (eg, worsening agitation or function). Cholinesterase inhibitors should be tapered over a two- to three-week period. (See  <a class="medical medical_review" href="/z/d/html/5072.html" rel="external">"Cholinesterase inhibitors in the treatment of dementia", section on 'Other reasons for discontinuation'</a>.)</p><p class="headingAnchor" id="H2012404051"><span class="h3">Other medications</span><span class="headingEndMark"> — </span>A consensus panel of experts has identified medications that are inappropriate in advanced dementia [<a href="#rid99">99,100</a>]. Chronic daily medications assessed to be "never appropriate" include lipid-lowering agents, cytotoxic chemotherapy, immunomodulators, leukotriene inhibitors, antiestrogens, sex hormones, hormone antagonists, and antiplatelet agents (except <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a>). Those assessed to be "rarely appropriate" include <a class="drug drug_general" data-topicid="9360" href="/z/d/drug information/9360.html" rel="external">digoxin</a>, <a class="drug drug_general" data-topicid="9285" href="/z/d/drug information/9285.html" rel="external">clonidine</a>, <a class="drug drug_general" data-topicid="8528" href="/z/d/drug information/8528.html" rel="external">hydralazine</a>, antiarrhythmics, mineralocorticoids, bladder relaxants, <a class="drug drug_general" data-topicid="9654" href="/z/d/drug information/9654.html" rel="external">tamsulosin</a>, antispasmodics, bisphosphonates, and anticoagulants.</p><p>In studies of patients with advanced dementia in nursing homes, 54 to 86 percent of patients receive at least one of these medications [<a href="#rid101">101,102</a>]. In one of the studies, drugs of questionable benefit accounted for 35 percent of the total average 90-day medication expenditures [<a href="#rid101">101</a>].</p><p>An overall discussion of deprescribing is provided separately. (See  <a class="medical medical_review" href="/z/d/html/122694.html" rel="external">"Deprescribing"</a>.)</p><p class="headingAnchor" id="H2773414917"><span class="h1">END-OF-LIFE CARE</span><span class="headingEndMark"> — </span>It can be helpful for families to identify when death may be imminent. Clinical signs can be used to identify patients who are actively dying  (<a class="graphic graphic_table graphicRef88520" href="/z/d/graphic/88520.html" rel="external">table 5</a>).</p><p>Other aspects of care in the last hours and days of life are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/14244.html" rel="external">"Stopping nutrition and hydration at the end of life"</a> and  <a class="medical medical_review" href="/z/d/html/14241.html" rel="external">"Palliative care: The last hours and days of life"</a>.)</p><p class="headingAnchor" id="H2449572779"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/111340.html" rel="external">"Society guideline links: Nutrition support (parenteral and enteral nutrition) in adults"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/116344.html" rel="external">"Society guideline links: Cognitive impairment and dementia"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/119531.html" rel="external">"Society guideline links: Palliative care"</a>.)</p><p class="headingAnchor" id="H423254626"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features and course</strong> – Advanced dementia typically refers to a state of profound physical and cognitive disability that is the result of a variety of neurodegenerative diseases, the most common of which is Alzheimer disease (AD). The clinical stages of dementia are well described, but the time course of progression is variable. (See <a class="local">'Clinical course'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Advance care planning</strong> – Advance care planning is the cornerstone of high-quality care in advanced dementia. Patients with dementia and their families should be informed about what to expect at the end stage of the disease. Goals of care should be ascertained and re-evaluated as the patient progresses. Formal advance directives and an appointment of a health care proxy should be ascertained prior to the end stage of dementia. (See <a class="local">'Advance care planning'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hospice and palliative care</strong> – When available, referral to hospice or specialized palliative care services should be considered in the care plan of patients with advanced dementia. Although eligibility for formal hospice programs is often based upon estimated life expectancy, provision of palliative care should be guided instead by a preference for comfort-focused care. (See <a class="local">'Hospice and palliative care'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Feeding and nutrition</strong> – Feeding problems are a common clinical complication and source of treatment decisions in advanced dementia. Conservative measures that may improve oral intake include altering the texture of food and offering finger foods, smaller portions, favorite foods, and nutritional supplements.</p><p></p><p class="bulletIndent1">When feeding problems persist despite conservative measures, we suggest continued oral feeding by hand rather than tube feeding for nutritional support (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Feeding and nutrition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infections</strong> – Recurrent infections are a common complication of advanced dementia but may be challenging to diagnose and appropriately manage. To avoid misuse of antimicrobials, clinicians should ensure that minimal criteria to suspect an infection are present before initiating testing and treatment  (<a class="graphic graphic_table graphicRef89843" href="/z/d/graphic/89843.html" rel="external">table 3</a>), and antimicrobial use should be aligned with patient and family or caregiver goals of care. (See <a class="local">'Infections and fever'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Discontinuing chronic daily medications</strong> – Chronic daily medications should be discontinued by tapering them, if possible, when they no longer have clear benefits for patients with advanced dementia. (See <a class="local">'Discontinuing chronic medications'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Rajan KB, Weuve J, Barnes LL, et al. Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060). Alzheimers Dement 2021; 17:1966.</a></li><li class="breakAll">2023 Alzheimer’s disease facts and figures. Alzheimer's Association. https://www.alz.org/media/Documents/alzheimers-facts-and-figures.pdf (Accessed on March 11, 2023).</li><li><a class="nounderline abstract_t">Heron M. Deaths: Leading Causes for 2019. Natl Vital Stat Rep 2021; 70:1.</a></li><li><a class="nounderline abstract_t">Hurd MD, Martorell P, Delavande A, et al. Monetary costs of dementia in the United States. N Engl J Med 2013; 368:1326.</a></li><li><a class="nounderline abstract_t">Walsh SC, Murphy E, Devane D, et al. Palliative care interventions in advanced dementia. Cochrane Database Syst Rev 2021; 9:CD011513.</a></li><li><a class="nounderline abstract_t">Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139:1136.</a></li><li><a class="nounderline abstract_t">Mitchell SL, Black BS, Ersek M, et al. Advanced dementia: state of the art and priorities for the next decade. Ann Intern Med 2012; 156:45.</a></li><li><a class="nounderline abstract_t">Gill TM, Gahbauer EA, Han L, Allore HG. Trajectories of disability in the last year of life. N Engl J Med 2010; 362:1173.</a></li><li><a class="nounderline abstract_t">Mitchell SL, Teno JM, Kiely DK, et al. The clinical course of advanced dementia. N Engl J Med 2009; 361:1529.</a></li><li><a class="nounderline abstract_t">Jaul E, Meiron O. Advanced Dementia: Brain-State Characteristics and Clinical Indicators of Early Mortality. J Alzheimers Dis 2021; 81:933.</a></li><li><a class="nounderline abstract_t">Hsieh PC, Wu SC, Fuh JL, et al. The prognostic predictors of six-month mortality for residents with advanced dementia in long-term care facilities in Taiwan: A prospective cohort study. Int J Nurs Stud 2019; 96:9.</a></li><li><a class="nounderline abstract_t">Lee KC, Hsu WH, Chou PH, et al. Estimating the survival of elderly patients diagnosed with dementia in Taiwan: A longitudinal study. PLoS One 2018; 13:e0178997.</a></li><li><a class="nounderline abstract_t">Loizeau AJ, Shaffer ML, Habtemariam DA, et al. Association of Prognostic Estimates With Burdensome Interventions in Nursing Home Residents With Advanced Dementia. JAMA Intern Med 2018; 178:922.</a></li><li><a class="nounderline abstract_t">Medical guidelines for determining prognosis in selected non-cancer diseases. The National Hospice Organization. Hosp J 1996; 11:47.</a></li><li><a class="nounderline abstract_t">Mitchell SL, Miller SC, Teno JM, et al. Prediction of 6-month survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility guidelines. JAMA 2010; 304:1929.</a></li><li><a class="nounderline abstract_t">Mitchell SL, Kiely DK, Hamel MB, et al. Estimating prognosis for nursing home residents with advanced dementia. JAMA 2004; 291:2734.</a></li><li><a class="nounderline abstract_t">Schonwetter RS, Han B, Small BJ, et al. Predictors of six-month survival among patients with dementia: an evaluation of hospice Medicare guidelines. Am J Hosp Palliat Care 2003; 20:105.</a></li><li><a class="nounderline abstract_t">Marsh GW, Prochoda KP, Pritchett E, Vojir CP. Predicting hospice appropriateness for patients with dementia of the Alzheimer's type. Appl Nurs Res 2000; 13:187.</a></li><li><a class="nounderline abstract_t">Brown MA, Sampson EL, Jones L, Barron AM. Prognostic indicators of 6-month mortality in elderly people with advanced dementia: a systematic review. Palliat Med 2013; 27:389.</a></li><li><a class="nounderline abstract_t">Lopes BNA, Garcez FB, Suemoto CK, Morillo LS. Accuracy of two prognostic indexes to predict mortality in older adults with advanced dementia. Dement Neuropsychol 2022; 16:52.</a></li><li><a class="nounderline abstract_t">Morris JN, Hawes C, Fries BE, et al. Designing the national resident assessment instrument for nursing homes. Gerontologist 1990; 30:293.</a></li><li><a class="nounderline abstract_t">Mitchell SL, Miller SC, Teno JM, et al. The advanced dementia prognostic tool: a risk score to estimate survival in nursing home residents with advanced dementia. J Pain Symptom Manage 2010; 40:639.</a></li><li><a class="nounderline abstract_t">Gillick MR. Rethinking the role of tube feeding in patients with advanced dementia. N Engl J Med 2000; 342:206.</a></li><li><a class="nounderline abstract_t">Buchanan A, Brock DW. Deciding for others. Milbank Q 1986; 64:17.</a></li><li><a class="nounderline abstract_t">Mitchell SL, Shaffer ML, Cohen S, et al. An Advance Care Planning Video Decision Support Tool for Nursing Home Residents With Advanced Dementia: A Cluster Randomized Clinical Trial. JAMA Intern Med 2018; 178:961.</a></li><li><a class="nounderline abstract_t">Gozalo P, Teno JM, Mitchell SL, et al. End-of-life transitions among nursing home residents with cognitive issues. N Engl J Med 2011; 365:1212.</a></li><li><a class="nounderline abstract_t">Mitchell SL, Teno JM, Intrator O, et al. Decisions to forgo hospitalization in advanced dementia: a nationwide study. J Am Geriatr Soc 2007; 55:432.</a></li><li><a class="nounderline abstract_t">Goldfeld KS, Stevenson DG, Hamel MB, Mitchell SL. Medicare expenditures among nursing home residents with advanced dementia. Arch Intern Med 2011; 171:824.</a></li><li><a class="nounderline abstract_t">Nicholas LH, Bynum JP, Iwashyna TJ, et al. Advance directives and nursing home stays associated with less aggressive end-of-life care for patients with severe dementia. Health Aff (Millwood) 2014; 33:667.</a></li><li><a class="nounderline abstract_t">Vandervoort A, van den Block L, van der Steen JT, et al. Advance directives and physicians' orders in nursing home residents with dementia in Flanders, Belgium: prevalence and associated outcomes. Int Psychogeriatr 2012; 24:1133.</a></li><li><a class="nounderline abstract_t">Wendrich-van Dael A, Bunn F, Lynch J, et al. Advance care planning for people living with dementia: An umbrella review of effectiveness and experiences. Int J Nurs Stud 2020; 107:103576.</a></li><li><a class="nounderline abstract_t">Gaster B, Larson EB, Curtis JR. Advance Directives for Dementia: Meeting a Unique Challenge. JAMA 2017; 318:2175.</a></li><li><a class="nounderline abstract_t">Piers R, Albers G, Gilissen J, et al. Advance care planning in dementia: recommendations for healthcare professionals. BMC Palliat Care 2018; 17:88.</a></li><li><a class="nounderline abstract_t">Mitchell SL. CLINICAL PRACTICE. Advanced Dementia. N Engl J Med 2015; 372:2533.</a></li><li><a class="nounderline abstract_t">Mitchell SL, Kiely DK, Lipsitz LA. The risk factors and impact on survival of feeding tube placement in nursing home residents with severe cognitive impairment. Arch Intern Med 1997; 157:327.</a></li><li><a class="nounderline abstract_t">Mitchell SL, Teno JM, Roy J, et al. Clinical and organizational factors associated with feeding tube use among nursing home residents with advanced cognitive impairment. JAMA 2003; 290:73.</a></li><li><a class="nounderline abstract_t">Givens JL, Selby K, Goldfeld KS, Mitchell SL. Hospital transfers of nursing home residents with advanced dementia. J Am Geriatr Soc 2012; 60:905.</a></li><li><a class="nounderline abstract_t">Houttekier D, Vandervoort A, Van den Block L, et al. Hospitalizations of nursing home residents with dementia in the last month of life: results from a nationwide survey. Palliat Med 2014; 28:1110.</a></li><li><a class="nounderline abstract_t">Givens JL, Jones RN, Shaffer ML, et al. Survival and comfort after treatment of pneumonia in advanced dementia. Arch Intern Med 2010; 170:1102.</a></li><li><a class="nounderline abstract_t">Engel SE, Kiely DK, Mitchell SL. Satisfaction with end-of-life care for nursing home residents with advanced dementia. J Am Geriatr Soc 2006; 54:1567.</a></li><li><a class="nounderline abstract_t">Givens JL, Prigerson HG, Kiely DK, et al. Grief among family members of nursing home residents with advanced dementia. Am J Geriatr Psychiatry 2011; 19:543.</a></li><li><a class="nounderline abstract_t">Givens JL, Prigerson HG, Jones RN, Mitchell SL. Mental health and exposure to patient distress among families of nursing home residents with advanced dementia. J Pain Symptom Manage 2011; 42:183.</a></li><li><a class="nounderline abstract_t">Kiely DK, Givens JL, Shaffer ML, et al. Hospice use and outcomes in nursing home residents with advanced dementia. J Am Geriatr Soc 2010; 58:2284.</a></li><li class="breakAll">The Conversation Project. Institute for Healthcare Improvement. https://theconversationproject.org/get-started (Accessed on February 22, 2023).</li><li><a class="nounderline abstract_t">Murphy E, Froggatt K, Connolly S, et al. Palliative care interventions in advanced dementia. Cochrane Database Syst Rev 2016; 12:CD011513.</a></li><li><a class="nounderline abstract_t">Hanson LC, Zimmerman S, Song MK, et al. Effect of the Goals of Care Intervention for Advanced Dementia: A Randomized Clinical Trial. JAMA Intern Med 2017; 177:24.</a></li><li><a class="nounderline abstract_t">Mitchell SL, Teno JM, Miller SC, Mor V. A national study of the location of death for older persons with dementia. J Am Geriatr Soc 2005; 53:299.</a></li><li><a class="nounderline abstract_t">Teno JM, Mitchell SL, Skinner J, et al. Churning: the association between health care transitions and feeding tube insertion for nursing home residents with advanced cognitive impairment. J Palliat Med 2009; 12:359.</a></li><li><a class="nounderline abstract_t">Loeb M, Carusone SC, Goeree R, et al. Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial. JAMA 2006; 295:2503.</a></li><li><a class="nounderline abstract_t">Goldfeld KS, Hamel MB, Mitchell SL. The cost-effectiveness of the decision to hospitalize nursing home residents with advanced dementia. J Pain Symptom Manage 2013; 46:640.</a></li><li><a class="nounderline abstract_t">Morrison RS, Ahronheim JC, Morrison GR, et al. Pain and discomfort associated with common hospital procedures and experiences. J Pain Symptom Manage 1998; 15:91.</a></li><li><a class="nounderline abstract_t">Luchins DJ, Hanrahan P. What is appropriate health care for end-stage dementia? J Am Geriatr Soc 1993; 41:25.</a></li><li><a class="nounderline abstract_t">Teno JM, Gozalo PL, Bynum JP, et al. Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009. JAMA 2013; 309:470.</a></li><li><a class="nounderline abstract_t">Miller SC, Gozalo P, Mor V. Hospice enrollment and hospitalization of dying nursing home patients. Am J Med 2001; 111:38.</a></li><li><a class="nounderline abstract_t">Miller SC, Mor V, Wu N, et al. Does receipt of hospice care in nursing homes improve the management of pain at the end of life? J Am Geriatr Soc 2002; 50:507.</a></li><li><a class="nounderline abstract_t">Shega JW, Hougham GW, Stocking CB, et al. Patients dying with dementia: experience at the end of life and impact of hospice care. J Pain Symptom Manage 2008; 35:499.</a></li><li><a class="nounderline abstract_t">Harrison KL, Cenzer I, Ankuda CK, et al. Hospice Improves Care Quality For Older Adults With Dementia In Their Last Month Of Life. Health Aff (Millwood) 2022; 41:821.</a></li><li><a class="nounderline abstract_t">Miller SC, Lima JC, Intrator O, et al. Specialty Palliative Care Consultations for Nursing Home Residents With Dementia. J Pain Symptom Manage 2017; 54:9.</a></li><li><a class="nounderline abstract_t">Hanson LC, Kistler CE, Lavin K, et al. Triggered Palliative Care for Late-Stage Dementia: A Pilot Randomized Trial. J Pain Symptom Manage 2019; 57:10.</a></li><li><a class="nounderline abstract_t">Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull 1988; 24:653.</a></li><li class="breakAll">NHPCO: Facts and Figures, 2012. National Hospice and Palliative Care Organization. http://www.nhpco.org/sites/default/files/public/Statistics_Research/2012_Facts_Figures.pdf (Accessed on March 29, 2013).</li><li><a class="nounderline abstract_t">Hanson LC, Ersek M, Gilliam R, Carey TS. Oral feeding options for people with dementia: a systematic review. J Am Geriatr Soc 2011; 59:463.</a></li><li><a class="nounderline abstract_t">American Geriatrics Society Ethics Committee and Clinical Practice and Models of Care Committee. American Geriatrics Society feeding tubes in advanced dementia position statement. J Am Geriatr Soc 2014; 62:1590.</a></li><li><a class="nounderline abstract_t">Lam RE, Lam PJ. Nutrition in dementia. CMAJ 2014; 186:1319.</a></li><li class="breakAll">Feeding tubes for people with Alzheimer's Disease. Choosing Wisely. http://www.choosingwisely.org/wp-content/uploads/2014/05/CR-ChoosingWiselyFeedingTubeAGS-ER_052013.pdf (Accessed on September 05, 2014).</li><li><a class="nounderline abstract_t">Finucane TE, Christmas C, Travis K. Tube feeding in patients with advanced dementia: a review of the evidence. JAMA 1999; 282:1365.</a></li><li><a class="nounderline abstract_t">Christmas C, Finucane TE. Tube feeding and pressure ulcers: comment on "Feeding tubes and the prevention or healing of pressure ulcers". Arch Intern Med 2012; 172:701.</a></li><li><a class="nounderline abstract_t">Lee YF, Hsu TW, Liang CS, et al. The Efficacy and Safety of Tube Feeding in Advanced Dementia Patients: A Systemic Review and Meta-Analysis Study. J Am Med Dir Assoc 2021; 22:357.</a></li><li><a class="nounderline abstract_t">Hanson LC, Carey TS, Caprio AJ, et al. Improving decision-making for feeding options in advanced dementia: a randomized, controlled trial. J Am Geriatr Soc 2011; 59:2009.</a></li><li><a class="nounderline abstract_t">Mitchell SL, Buchanan JL, Littlehale S, Hamel MB. Tube-feeding versus hand-feeding nursing home residents with advanced dementia: a cost comparison. J Am Med Dir Assoc 2003; 4:27.</a></li><li><a class="nounderline abstract_t">Mitchell SL, Berkowitz RE, Lawson FM, Lipsitz LA. A cross-national survey of tube-feeding decisions in cognitively impaired older persons. J Am Geriatr Soc 2000; 48:391.</a></li><li><a class="nounderline abstract_t">Callahan CM, Haag KM, Buchanan NN, Nisi R. Decision-making for percutaneous endoscopic gastrostomy among older adults in a community setting. J Am Geriatr Soc 1999; 47:1105.</a></li><li><a class="nounderline abstract_t">Davies N, Barrado-Martín Y, Vickerstaff V, et al. Enteral tube feeding for people with severe dementia. Cochrane Database Syst Rev 2021; 8:CD013503.</a></li><li><a class="nounderline abstract_t">Yuen JK, Luk JKH, Chan TC, et al. Reduced Pneumonia Risk in Advanced Dementia Patients on Careful Hand Feeding Compared With Nasogastric Tube Feeding. J Am Med Dir Assoc 2022; 23:1541.</a></li><li><a class="nounderline abstract_t">Peck A, Cohen CE, Mulvihill MN. Long-term enteral feeding of aged demented nursing home patients. J Am Geriatr Soc 1990; 38:1195.</a></li><li><a class="nounderline abstract_t">Teno JM, Gozalo P, Mitchell SL, et al. Feeding tubes and the prevention or healing of pressure ulcers. Arch Intern Med 2012; 172:697.</a></li><li><a class="nounderline abstract_t">D'Agata E, Mitchell SL. Patterns of antimicrobial use among nursing home residents with advanced dementia. Arch Intern Med 2008; 168:357.</a></li><li><a class="nounderline abstract_t">Mitchell SL, D'Agata EMC, Hanson LC, et al. The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial. JAMA Intern Med 2021; 181:1174.</a></li><li><a class="nounderline abstract_t">Chen JH, Lamberg JL, Chen YC, et al. Occurrence and treatment of suspected pneumonia in long-term care residents dying with advanced dementia. J Am Geriatr Soc 2006; 54:290.</a></li><li><a class="nounderline abstract_t">Mody L. Optimizing antimicrobial use in nursing homes: no longer optional. J Am Geriatr Soc 2007; 55:1301.</a></li><li><a class="nounderline abstract_t">Loeb M, Bentley DW, Bradley S, et al. Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol 2001; 22:120.</a></li><li><a class="nounderline abstract_t">Yoshikawa TT. Resistant pathogens: considerations in geriatrics and infectious disease. J Am Geriatr Soc 2002; 50:S225.</a></li><li><a class="nounderline abstract_t">D'Agata E, Loeb MB, Mitchell SL. Challenges in assessing nursing home residents with advanced dementia for suspected urinary tract infections. J Am Geriatr Soc 2013; 61:62.</a></li><li><a class="nounderline abstract_t">Mitchell SL, Shaffer ML, Kiely DK, et al. The study of pathogen resistance and antimicrobial use in dementia: study design and methodology. Arch Gerontol Geriatr 2013; 56:16.</a></li><li><a class="nounderline abstract_t">Yoshikawa TT. Antimicrobial resistance and aging: beginning of the end of the antibiotic era? J Am Geriatr Soc 2002; 50:S226.</a></li><li><a class="nounderline abstract_t">Pop-Vicas A, Mitchell SL, Kandel R, et al. Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors. J Am Geriatr Soc 2008; 56:1276.</a></li><li><a class="nounderline abstract_t">Mitchell SL, Shaffer ML, Loeb MB, et al. Infection management and multidrug-resistant organisms in nursing home residents with advanced dementia. JAMA Intern Med 2014; 174:1660.</a></li><li><a class="nounderline abstract_t">Kyne L, Merry C, O'Connell B, et al. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. Age Ageing 1999; 28:107.</a></li><li><a class="nounderline abstract_t">Faulkner CM, Cox HL, Williamson JC. Unique aspects of antimicrobial use in older adults. Clin Infect Dis 2005; 40:997.</a></li><li><a class="nounderline abstract_t">Volicer L, Hurley AC, Blasi ZV. Scales for evaluation of End-of-Life Care in Dementia. Alzheimer Dis Assoc Disord 2001; 15:194.</a></li><li><a class="nounderline abstract_t">Nicolle LE. Resistant pathogens in urinary tract infections. J Am Geriatr Soc 2002; 50:S230.</a></li><li><a class="nounderline abstract_t">Dufour AB, Shaffer ML, D'Agata EM, et al. Survival After Suspected Urinary Tract Infection in Individuals with Advanced Dementia. J Am Geriatr Soc 2015; 63:2472.</a></li><li><a class="nounderline abstract_t">Hendriks SA, Smalbrugge M, Hertogh CM, van der Steen JT. Dying with dementia: symptoms, treatment, and quality of life in the last week of life. J Pain Symptom Manage 2014; 47:710.</a></li><li><a class="nounderline abstract_t">Warden V, Hurley AC, Volicer L. Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. J Am Med Dir Assoc 2003; 4:9.</a></li><li><a class="nounderline abstract_t">Zumstein N, Yamada K, Eicher S, et al. The German version of the Mini Suffering State Examination (MSSE) for people with advanced dementia living in nursing homes. BMC Geriatr 2022; 22:595.</a></li><li><a class="nounderline abstract_t">Mosele M, Inelmen EM, Toffanello ED, et al. Psychometric properties of the pain assessment in advanced dementia scale compared to self assessment of pain in elderly patients. Dement Geriatr Cogn Disord 2012; 34:38.</a></li><li><a class="nounderline abstract_t">Pfisterer MH, Johnson TM 2nd, Jenetzky E, et al. Geriatric patients' preferences for treatment of urinary incontinence: a study of hospitalized, cognitively competent adults aged 80 and older. J Am Geriatr Soc 2007; 55:2016.</a></li><li><a class="nounderline abstract_t">Gormley EA, Lightner DJ, Faraday M, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol 2015; 193:1572.</a></li><li><a class="nounderline abstract_t">Holmes HM, Sachs GA, Shega JW, et al. Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use. J Am Geriatr Soc 2008; 56:1306.</a></li><li><a class="nounderline abstract_t">Tjia J, Rothman MR, Kiely DK, et al. Daily medication use in nursing home residents with advanced dementia. J Am Geriatr Soc 2010; 58:880.</a></li><li><a class="nounderline abstract_t">Tjia J, Briesacher BA, Peterson D, et al. Use of medications of questionable benefit in advanced dementia. JAMA Intern Med 2014; 174:1763.</a></li><li><a class="nounderline abstract_t">Matlow JN, Bronskill SE, Gruneir A, et al. Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia. J Am Geriatr Soc 2017; 65:1535.</a></li></ol></div><div id="topicVersionRevision">Topic 86250 Version 38.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34043283" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34043283" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34520342" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Deaths: Leading Causes for 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23550670" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Monetary costs of dementia in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34582034" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Palliative care interventions in advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7114305" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The Global Deterioration Scale for assessment of primary degenerative dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22213494" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Advanced dementia: state of the art and priorities for the next decade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20357280" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Trajectories of disability in the last year of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19828530" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The clinical course of advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33843676" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Advanced Dementia: Brain-State Characteristics and Clinical Indicators of Early Mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30679035" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The prognostic predictors of six-month mortality for residents with advanced dementia in long-term care facilities in Taiwan: A prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30044781" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Estimating the survival of elderly patients diagnosed with dementia in Taiwan: A longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29813159" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Association of Prognostic Estimates With Burdensome Interventions in Nursing Home Residents With Advanced Dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8949013" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Medical guidelines for determining prognosis in selected non-cancer diseases. The National Hospice Organization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21045099" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Prediction of 6-month survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15187055" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Estimating prognosis for nursing home residents with advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12693642" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Predictors of six-month survival among patients with dementia: an evaluation of hospice Medicare guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11078784" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Predicting hospice appropriateness for patients with dementia of the Alzheimer's type.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23175514" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Prognostic indicators of 6-month mortality in elderly people with advanced dementia: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35719252" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Accuracy of two prognostic indexes to predict mortality in older adults with advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2354790" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Designing the national resident assessment instrument for nursing homes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20621437" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The advanced dementia prognostic tool: a risk score to estimate survival in nursing home residents with advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10639550" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Rethinking the role of tube feeding in patients with advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11649884" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Deciding for others.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29868778" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : An Advance Care Planning Video Decision Support Tool for Nursing Home Residents With Advanced Dementia: A Cluster Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21991894" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : End-of-life transitions among nursing home residents with cognitive issues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17341248" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Decisions to forgo hospitalization in advanced dementia: a nationwide study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21220646" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Medicare expenditures among nursing home residents with advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24711329" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Advance directives and nursing home stays associated with less aggressive end-of-life care for patients with severe dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22364648" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Advance directives and physicians' orders in nursing home residents with dementia in Flanders, Belgium: prevalence and associated outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32380259" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Advance care planning for people living with dementia: An umbrella review of effectiveness and experiences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29114779" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Advance Directives for Dementia: Meeting a Unique Challenge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29933758" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Advance care planning in dementia: recommendations for healthcare professionals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26107053" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : CLINICAL PRACTICE. Advanced Dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9040301" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The risk factors and impact on survival of feeding tube placement in nursing home residents with severe cognitive impairment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12837714" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Clinical and organizational factors associated with feeding tube use among nursing home residents with advanced cognitive impairment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22428661" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Hospital transfers of nursing home residents with advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24866759" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Hospitalizations of nursing home residents with dementia in the last month of life: results from a nationwide survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20625013" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Survival and comfort after treatment of pneumonia in advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17038076" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Satisfaction with end-of-life care for nursing home residents with advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21606897" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Grief among family members of nursing home residents with advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21402461" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Mental health and exposure to patient distress among families of nursing home residents with advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21143437" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Hospice use and outcomes in nursing home residents with advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21143437" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Hospice use and outcomes in nursing home residents with advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27911489" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Palliative care interventions in advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27893884" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Effect of the Goals of Care Intervention for Advanced Dementia: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15673356" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : A national study of the location of death for older persons with dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19327073" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Churning: the association between health care transitions and feeding tube insertion for nursing home residents with advanced cognitive impairment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16757722" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23571207" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The cost-effectiveness of the decision to hospitalize nursing home residents with advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9494307" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Pain and discomfort associated with common hospital procedures and experiences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7678104" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : What is appropriate health care for end-stage dementia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23385273" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11448659" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Hospice enrollment and hospitalization of dying nursing home patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11943048" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Does receipt of hospice care in nursing homes improve the management of pain at the end of life?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18261878" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Patients dying with dementia: experience at the end of life and impact of hospice care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35666964" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Hospice Improves Care Quality For Older Adults With Dementia In Their Last Month Of Life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28438589" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Specialty Palliative Care Consultations for Nursing Home Residents With Dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30342242" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Triggered Palliative Care for Late-Stage Dementia: A Pilot Randomized Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3249767" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Functional assessment staging (FAST).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3249767" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Functional assessment staging (FAST).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21391936" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Oral feeding options for people with dementia: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25039796" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : American Geriatrics Society feeding tubes in advanced dementia position statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25332369" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Nutrition in dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25332369" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Nutrition in dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10527184" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Tube feeding in patients with advanced dementia: a review of the evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22782197" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Tube feeding and pressure ulcers: comment on "Feeding tubes and the prevention or healing of pressure ulcers".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32736992" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : The Efficacy and Safety of Tube Feeding in Advanced Dementia Patients: A Systemic Review and Meta-Analysis Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22091750" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Improving decision-making for feeding options in advanced dementia: a randomized, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12807594" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Tube-feeding versus hand-feeding nursing home residents with advanced dementia: a cost comparison.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10798465" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : A cross-national survey of tube-feeding decisions in cognitively impaired older persons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10484254" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Decision-making for percutaneous endoscopic gastrostomy among older adults in a community setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34387363" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Enteral tube feeding for people with severe dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35489380" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Reduced Pneumonia Risk in Advanced Dementia Patients on Careful Hand Feeding Compared With Nasogastric Tube Feeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2123217" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Long-term enteral feeding of aged demented nursing home patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22782196" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Feeding tubes and the prevention or healing of pressure ulcers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18299489" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Patterns of antimicrobial use among nursing home residents with advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34251396" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16460381" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Occurrence and treatment of suspected pneumonia in long-term care residents dying with advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17661973" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Optimizing antimicrobial use in nursing homes: no longer optional.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11232875" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12121516" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Resistant pathogens: considerations in geriatrics and infectious disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23311553" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Challenges in assessing nursing home residents with advanced dementia for suspected urinary tract infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22925431" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : The study of pathogen resistance and antimicrobial use in dementia: study design and methodology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12121517" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Antimicrobial resistance and aging: beginning of the end of the antibiotic era?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18557965" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25133863" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Infection management and multidrug-resistant organisms in nursing home residents with advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10350405" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Factors associated with prolonged symptoms and severe disease due to Clostridium difficile.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15824992" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Unique aspects of antimicrobial use in older adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11723370" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Scales for evaluation of End-of-Life Care in Dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12121518" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Resistant pathogens in urinary tract infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26613981" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Survival After Suspected Urinary Tract Infection in Individuals with Advanced Dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23916680" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Dying with dementia: symptoms, treatment, and quality of life in the last week of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12807591" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35850694" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : The German version of the Mini Suffering State Examination (MSSE) for people with advanced dementia living in nursing homes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22907210" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Psychometric properties of the pain assessment in advanced dementia scale compared to self assessment of pain in elderly patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17979956" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Geriatric patients' preferences for treatment of urinary incontinence: a study of hospitalized, cognitively competent adults aged 80 and older.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25623739" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18482301" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20406320" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Daily medication use in nursing home residents with advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25201279" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Use of medications of questionable benefit in advanced dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28369696" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
